Privia Health Group, Inc.
Privia Health Group, Inc. is a healthcare company based in Arlington, Virginia, operating within the medical healthcare information services industry. Founded in 2007, the company functions as a national entity focused on empowering physicians throughout the United States. It partners with medical groups, health…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
1D
-0.4%
1W
+8.0%
1M
+10.6%
6M
-6.2%
YTD
-5.0%
1Y
-11.8%
2Y
+24.4%
5Y
-4.2%
10Y
–
Next earnings date
05/11/2026 (in 19 days)
Volatility around earnings
~79% stronger price swings than usual
PRICE TARGET LOW
US$24.00
CONSENSUS
US$28.00
MEDIAN
US$28.00
PRICE TARGET HIGH
US$32.00
0
STRONG BUY
20
BUY
2
HOLD
0
SELL
0
STRONG SELL
22
TOTAL · Buy
As of: 26/05/2026
P/E
100.13
P/B
0
EV/EBITDA
-5,876.69
RETURN ON EQUITY
0.0%
NET MARGIN
1.4%
DEBT/EQUITY
0.01
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
85.3%
FLOAT SHARES
108,949,615
AVG. DAILY VOLUME (30D)
1,346,137
Ernest Opella Finley
Mountcastle David
Mountcastle David
Morris Matthew Shawn
Morris Matthew Shawn
Privia Health Group, Inc. is a company in the Healthcare sector, Medical - Healthcare Information Services industry, headquartered in United States.
The CEO is Parth Mehrotra, the company employs around 1,226 people.
The IPO was on 28/04/2021; the stock trades on NASDAQ under the ticker PRVA.
22 analysts rate the stock, the consensus is Buy (as of 26/05/2026).
The average price target is US$28.00, ranging from US$24.00 to US$32.00, with a median of US$28.00.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 05/11/2026.
Around past earnings, price swings were roughly 79% stronger than usual.
No, Privia Health Group currently does not pay a dividend.
Comparable stocks include Hinge Health, HealthEquity, Heartflow, Omada Health, Teladoc Health, Evolent Health, SOPHiA GENETICS and Optima Health.
Clicking "Analyze stock" lets five strategies assess Privia Health Group against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.